How is Covid-19 upending drug development? An industry leader weighs in
STAT spoke about Covid-19’s effect on pharma with Ken Moch, a former board member of BIO who has also run several small drug companies.
Related Articles
Colorado lawmakers revise effort to exempt rare disease drugs from state cost caps
Colorado lawmakers are abandoning a bill that would have required a new state board — chartered with setting caps for the cost of medicines — to…
2024 STAT Breakthrough Summit West: Medicine’s Future, Now
STAT Breakthrough Summit West is one-day event designed to break down silos across health and medicine by bringing together leaders, entrepreneurs, policymakers, patient advocates —…
Biohaven’s data delay degrades stock price
Shares in Biohaven fell 16% yesterday after the company offered investors a double dose of confusing updates about a closely followed drug.
Pharmalittle: We’re reading about CVS and Humira biosimilars, Schumer’s broken insulin promise, and more
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week…
Intra-Cellular reports positive results in depression study aimed at expanding use of antispsychotic medicine
Intra-Cellular Therapies reported positive results from a late-stage clinical trial seeking to expand the use of its antipsychotic medicine to patients with major depressive disorder.
Autism doesn’t discriminate. Autism research shouldn’t either
New research documents the social and systemic barriers that families of color face as they navigate the complex world of autism diagnosis and access to…
Grocers are pushing legislation they claim would enhance food safety. Advocates say it would gut FDA rules
The lobby representing food retailers has applauded a bipartisan bill that it says “enhances food safety.” Food safety advocates say it would do the opposite.
A new PIPE lawsuit challenges the fairness of sharing confidential, stock-moving information
The fairness of PIPEs, particularly the preferential sharing of confidential, stock-moving information, is now a legal question, @adamfeuerstein writes.
Chuck Schumer’s broken promise on affordable insulin
For more than two years, Sen. Chuck Schumer has been promising to hold a vote to make insulin affordable for people with all types of…
2024 STAT Breakthrough Summit West: Medicine’s Future, Now
STAT Breakthrough Summit West is one-day event designed to break down silos across health and medicine by bringing together leaders, entrepreneurs, policymakers, patient advocates —…